“…It is widely used as a hepatoprotective (Saraswat et al, 1999) in various formulations such as Picroliv (Ansari et al, 1991), Katuki, Arogya, Livomap and Kutaki (Bhandari et al, 2009), and also possesses other pharmacological activities such as anti-carcinogenic (Joy et al, 2000), anti-oxidant (Rajkumar et al, 2011), immunomodulatory (Gupta et al, 2006), anti-allergic, anti-asthmatic (Dorsch et al, 1991), superoxide scavenging (Chander et al, 1992) and anti-diabetic (Joy and Kuttan, 1999) properties. Picrorhiza kurroa contains two major medicinal components, picroside-I (P-I) and picroside-II (P-II) along with kutkoside (Singh and Rastogi, 1972), picroside-III (P-III) (Weinges et al, 1972), picroside-IV (P-IV), verminoside, specioside (Li et al, 1998) and other iridoid-glucosides (Table 1) (Mondal et al, 2012). The increasing demand, limited cultivation and reckless collection from the wild have rendered P. kurroa a critically endangered plant species (Rai et al, 2000;Mehra et al, 2011;Sood and Chauhan, 2011).…”